USC/Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave., #3447, Los Angeles, CA, 90033, USA,
Support Care Cancer. 2014 Jun;22(6):1601-10. doi: 10.1007/s00520-014-2127-1. Epub 2014 Jan 30.
This study aims to explore physician-patient communications about bone metastases and cancer treatment-induced bone loss (CTIBL).
The study utilizes online survey of patients with breast cancer, prostate cancer, and multiple myeloma, and the physicians who treat them.
Even though 69 and 48 % of patients with nonmetastatic breast and prostate cancer aware of treatment-induced bone loss, only 39 and 23 %, respectively, were concerned about bone loss. Yet, 62 and 71 % of oncologists treating breast and prostate cancer felt that their patients were concerned. Among patients with metastatic breast and prostate cancer, two thirds had not discussed treatment for bone metastases with their doctor; when discussed, 88 and 91 % of discussions were initiated by the doctor, usually prior to initiating treatment. Most myeloma patients (77 %) had discussed treatment options with their physicians; 99 % of hematologists reported discussing treatment of bone disease with patients.
Physicians are primary sources of information to patients regarding bone health. There is a gap between what physicians assume their patients know about bone health and the patients' perceptions, presenting a need for systematic awareness and education.
本研究旨在探讨医患之间关于骨转移和癌症治疗相关骨丢失（CTIBL）的沟通。
本研究对患有乳腺癌、前列腺癌和多发性骨髓瘤的患者以及治疗他们的医生进行了在线调查。
尽管 69%和 48%的非转移性乳腺癌和前列腺癌患者了解治疗相关的骨丢失，但只有 39%和 23%的患者对此表示担忧。然而，治疗乳腺癌和前列腺癌的 62%和 71%的肿瘤学家认为他们的患者对此表示关注。在转移性乳腺癌和前列腺癌患者中，有三分之二的患者尚未与医生讨论骨转移的治疗方法；当讨论时，88%和 91%的讨论是由医生发起的，通常是在开始治疗之前。大多数骨髓瘤患者（77%）与医生讨论了治疗方案；99%的血液学家报告说与患者讨论了骨疾病的治疗。
医生是患者了解骨骼健康的主要信息来源。医生认为患者对骨骼健康的了解与患者的认知之间存在差距，这需要进行系统的意识和教育。
